Literature DB >> 16116422

A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M.

Amom Ruhikanta Meetei1, Annette L Medhurst, Chen Ling, Yutong Xue, Thiyam Ramsing Singh, Patrick Bier, Jurgen Steltenpool, Stacie Stone, Inderjeet Dokal, Christopher G Mathew, Maureen Hoatlin, Hans Joenje, Johan P de Winter, Weidong Wang.   

Abstract

Fanconi anemia is a genetic disease characterized by genomic instability and cancer predisposition. Nine genes involved in Fanconi anemia have been identified; their products participate in a DNA damage-response network involving BRCA1 and BRCA2 (refs. 2,3). We previously purified a Fanconi anemia core complex containing the FANCL ubiquitin ligase and six other Fanconi anemia-associated proteins. Each protein in this complex is essential for monoubiquitination of FANCD2, a key reaction in the Fanconi anemia DNA damage-response pathway. Here we show that another component of this complex, FAAP250, is mutant in individuals with Fanconi anemia of a new complementation group (FA-M). FAAP250 or FANCM has sequence similarity to known DNA-repair proteins, including archaeal Hef, yeast MPH1 and human ERCC4 or XPF. FANCM can dissociate DNA triplex, possibly owing to its ability to translocate on duplex DNA. FANCM is essential for monoubiquitination of FANCD2 and becomes hyperphosphorylated in response to DNA damage. Our data suggest an evolutionary link between Fanconi anemia-associated proteins and DNA repair; FANCM may act as an engine that translocates the Fanconi anemia core complex along DNA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16116422      PMCID: PMC2704909          DOI: 10.1038/ng1626

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  30 in total

1.  The active site of the DNA repair endonuclease XPF-ERCC1 forms a highly conserved nuclease motif.

Authors:  Jacqueline H Enzlin; Orlando D Schärer
Journal:  EMBO J       Date:  2002-04-15       Impact factor: 11.598

2.  The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J.

Authors:  Marieke Levitus; Quinten Waisfisz; Barbara C Godthelp; Yne de Vries; Shobbir Hussain; Wouter W Wiegant; Elhaam Elghalbzouri-Maghrani; Jûrgen Steltenpool; Martin A Rooimans; Gerard Pals; Fré Arwert; Christopher G Mathew; Małgorzata Z Zdzienicka; Kevin Hiom; Johan P De Winter; Hans Joenje
Journal:  Nat Genet       Date:  2005-08-21       Impact factor: 38.330

3.  Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.

Authors:  I Garcia-Higuera; T Taniguchi; S Ganesan; M S Meyn; C Timmers; J Hejna; M Grompe; A D D'Andrea
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

4.  MPH1, a yeast gene encoding a DEAH protein, plays a role in protection of the genome from spontaneous and chemically induced damage.

Authors:  J Scheller; A Schürer; C Rudolph; S Hettwer; W Kramer
Journal:  Genetics       Date:  2000-07       Impact factor: 4.562

5.  Saccharomyces cerevisiae MPH1 gene, required for homologous recombination-mediated mutation avoidance, encodes a 3' to 5' DNA helicase.

Authors:  Rohit Prakash; Lumir Krejci; Stephen Van Komen; Kirsten Anke Schürer; Wilfried Kramer; Patrick Sung
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

Review 6.  The emerging genetic and molecular basis of Fanconi anaemia.

Authors:  H Joenje; K J Patel
Journal:  Nat Rev Genet       Date:  2001-06       Impact factor: 53.242

7.  Superhelicity-driven homologous DNA pairing by yeast recombination factors Rad51 and Rad54.

Authors:  S Van Komen; G Petukhova; S Sigurdsson; S Stratton; P Sung
Journal:  Mol Cell       Date:  2000-09       Impact factor: 17.970

8.  Cooperation of the N-terminal Helicase and C-terminal endonuclease activities of Archaeal Hef protein in processing stalled replication forks.

Authors:  Kayoko Komori; Masumi Hidaka; Takashi Horiuchi; Ryosuke Fujikane; Hideo Shinagawa; Yoshizumi Ishino
Journal:  J Biol Chem       Date:  2004-10-12       Impact factor: 5.157

9.  Human SNM1B is required for normal cellular response to both DNA interstrand crosslink-inducing agents and ionizing radiation.

Authors:  Ilja Demuth; Martin Digweed; Patrick Concannon
Journal:  Oncogene       Date:  2004-11-11       Impact factor: 9.867

10.  Generation of superhelical torsion by ATP-dependent chromatin remodeling activities.

Authors:  K Havas; A Flaus; M Phelan; R Kingston; P A Wade; D M Lilley; T Owen-Hughes
Journal:  Cell       Date:  2000-12-22       Impact factor: 41.582

View more
  212 in total

1.  FAAP20: a novel ubiquitin-binding FA nuclear core-complex protein required for functional integrity of the FA-BRCA DNA repair pathway.

Authors:  Abdullah Mahmood Ali; Arun Pradhan; Thiyam Ramsingh Singh; Changhu Du; Jie Li; Kebola Wahengbam; Elke Grassman; Arleen D Auerbach; Qishen Pang; Amom Ruhikanta Meetei
Journal:  Blood       Date:  2012-02-17       Impact factor: 22.113

Review 2.  Using synthetic DNA interstrand crosslinks to elucidate repair pathways and identify new therapeutic targets for cancer chemotherapy.

Authors:  Angelo Guainazzi; Orlando D Schärer
Journal:  Cell Mol Life Sci       Date:  2010-08-21       Impact factor: 9.261

Review 3.  Ubiquitin signalling in DNA replication and repair.

Authors:  Helle D Ulrich; Helen Walden
Journal:  Nat Rev Mol Cell Biol       Date:  2010-06-16       Impact factor: 94.444

4.  DNA crosslinking damage and cancer - a tale of friend and foe.

Authors:  Yaling Huang; Lei Li
Journal:  Transl Cancer Res       Date:  2013-06       Impact factor: 1.241

Review 5.  Advances in the understanding of the Fanconi anemia tumor suppressor pathway.

Authors:  Anna Pickering; Jun Zhang; Jayabal Panneerselvam; Peiwen Fei
Journal:  Cancer Biol Ther       Date:  2013-09-09       Impact factor: 4.742

6.  Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance.

Authors:  Gary P H Ho; Steven Margossian; Toshiyasu Taniguchi; Alan D D'Andrea
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

7.  Continuous in vivo infusion of interferon-gamma (IFN-gamma) enhances engraftment of syngeneic wild-type cells in Fanca-/- and Fancg-/- mice.

Authors:  Yue Si; Samantha Ciccone; Feng-Chun Yang; Jin Yuan; Daisy Zeng; Shi Chen; Henri J van de Vrugt; John Critser; Fre Arwert; Laura S Haneline; D Wade Clapp
Journal:  Blood       Date:  2006-08-31       Impact factor: 22.113

Review 8.  Survival of the fittest: in vivo selection and stem cell gene therapy.

Authors:  Tobias Neff; Brian C Beard; Hans-Peter Kiem
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

9.  Bi-allelic Recessive Loss-of-Function Variants in FANCM Cause Non-obstructive Azoospermia.

Authors:  Laura Kasak; Margus Punab; Liina Nagirnaja; Marina Grigorova; Ave Minajeva; Alexandra M Lopes; Anna Maria Punab; Kenneth I Aston; Filipa Carvalho; Eve Laasik; Lee B Smith; Donald F Conrad; Maris Laan
Journal:  Am J Hum Genet       Date:  2018-08-02       Impact factor: 11.025

Review 10.  Chromatin recruitment of DNA repair proteins: lessons from the fanconi anemia and double-strand break repair pathways.

Authors:  Martin A Cohn; Alan D D'Andrea
Journal:  Mol Cell       Date:  2008-11-07       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.